Zelboraf
European approval for Roche’s Zelboraf
February 20, 2012Sales and Marketing Cancer, Roche, Yervoy, Zelboraf, melanoma
Roche’s skin cancer pill Zelboraf has been given European approval to treat advanced melanoma. Zelboraf (vemurafenib) is now available in …
EMA panel gives positive opinion for Roche’s Zelboraf
December 16, 2011Sales and Marketing EMA, Roche, Zelboraf
The EMA’s advisory committee is recommending the approval of Roche’s skin cancer drug Zelboraf. The European regulator’s Committee for Medicinal …
Roche to show new cancer data at European congress
September 20, 2011Research and Development Cancer, Roche, T-DM1, Zelboraf, avastin
Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …
Roche’s Zelboraf approved by FDA months ahead of schedule
August 18, 2011Sales and Marketing Yervoy, Zelboraf, skin cancer
The FDA has approved Roche and Daiichi Sankyo’s new skin cancer drug Zelboraf two months ahead of schedule. Zelboraf (vemurafenib) …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
